Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-002439

Chief Business Officer sold 11,000 shares at $50.50 ($555,552)

  • Chief Business Officer acquired 14,037 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2025-01-02 Option exercise 10b5-1 +11,000 $3.29 $36,190 31,119 D
Robb Gary Charles Chief Business Officer 2025-01-02 Sale 10b5-1 −11,000 $50.50 $555,552 20,119 D
Robb Gary Charles Chief Business Officer 2025-01-03 Option exercise 10b5-1 +3,037 $3.29 $9,992 23,156 D
Derivatives
Robb Gary Charles Chief Business Officer 2025-01-02 Option exercise · Stock option (right to buy) 10b5-1 −11,000 3,037 D
Robb Gary Charles Chief Business Officer 2025-01-03 Option exercise · Stock option (right to buy) 10b5-1 −3,037 0 D
Open-market sales · 11,000 sh · avg $50.50 · $555,552
Loading xslF345X05/ownership.xml…